Back to the main directory
EarningsReview / Equity
- Danske Bank (Buy, TP: DKK240.00) - Concretised distribution agenda by DnB Markets
- Skanska (Buy, TP: SEK250.00) - Solid where it counts by DnB Markets
- Bonava (Hold, TP: SEK9.00) - Delayed earnings recovery by DnB Markets
- Lindab International (Buy, TP: SEK290.00) - Ready for market recovery by DnB Markets
- Beijer Ref (Hold, TP: SEK175.00) - Valuation stretched by DnB Markets
- AcadeMedia AB (Buy, TP: SEK65.00) - Solid Q4 headline numbers by DnB Markets
- Seafood - Fat Trout Weekly by DnB Markets
- Kasikornbank (KBANK TB) by HSBC
- Boliden (Buy, TP: SEK450.00) - Q2 should not be extrapolated by DnB Markets
- SAAB - Improved growth prospects for 2025 and beyond by Danske Bank Equity Research
- Electrolux - Q2 results still support a material H2 improvement by Danske Bank Equity Research
- Sandvik - Solid on mining orders by Danske Bank Equity Research
- Sandvik (Buy, TP: SEK270.00) - Positive view intact by DnB Markets
- Epiroc (Hold, TP: SEK225.00) - Fool me once, fool me four times by DnB Markets
- Truecaller (Buy, TP: SEK50.00) - Improved recurring revenue by DnB Markets
- Sinch (Buy, TP: SEK40.00) - Follow the money by DnB Markets
- ICICI Lombard (ICICIGI IN) by HSBC
- Slurry pipeline purchase opens a new growth frontier by BNP Paribas Exane
- Miss as we expected; caution further clouds growth outlook by BNP Paribas Exane
- Margin pain transient by BNP Paribas Exane
- Nippon AMC (NAM IN) by HSBC
- RH Intra-quarter catchup: our key takeaways by BNP Paribas Exane
- CreditAccess Grameen (CREDAG IN) by HSBC
- Alleima - Entering better markets in good shape by Danske Bank Equity Research
- Kone - Hold: China still weakening, other regions compensating by Nordea
- Alligator Bioscience (Buy, TP: SEK2.00) - Out-licensing deal next step by DnB Markets
- Pareto Bank (Buy, TP: NOK70.00) - Growth momentum picking up by DnB Markets
- Tomra (Sell, TP: NOK95.00) - Another volatile reaction by DnB Markets
- Betsson (Buy, TP: SEK175.00) - Player intake solidifying outlook by DnB Markets
- Humana (Hold, TP: SEK34.00) - Streamlining business portfolio by DnB Markets
- Evolution (Buy, TP: SEK1600.00) - Strong cash from a new Swedish… by DnB Markets
- More Q2 results, a profit warning and an equity raise by DnB Markets
- Nokian Tyres (Hold, TP: EUR8.50) - Neutral gear in Q2 by DnB Markets
- Tomra Systems - Several concerns answered by Danske Bank Equity Research
- Billerud - Showing there is more than meets the eye by Danske Bank Equity Research
- Epiroc - E&S margin improving by Danske Bank Equity Research
- Autoliv - Weaker LVP now discounted – up to Buy by Danske Bank Equity Research
- Autoliv (Buy, TP: SEK1320.00) - At the mercy of others by DnB Markets
- Wärtsilä (Buy, TP: EUR21.00) - Continued positive direction by DnB Markets
- Billerud (Buy, TP: SEK145.00) - Dressed for success by DnB Markets
- Reliance Industries (RELIANCE IN) by HSBC
- Impressive AUM growth despite seasonal headwinds by BNP Paribas Exane
- Focus on profitability visible by BNP Paribas Exane
- Muted 1Q for O2C and Retail; Jio to drive FY25 by BNP Paribas Exane
- The slow grind by BNP Paribas Exane
- Kotak Mahindra Bank (KMB IN) by HSBC
- Polycab India Limited (POLYCAB IN) by HSBC
- Boliden - Overcautious perception offers an opportunity by Danske Bank Equity Research
- Yara International - Buy/NOK 380: Cost and capex initiatives to improve profitability by Nordea
- Tomra Systems - Hold: A good, but not transformative quarter by Nordea